4
Changes in Ownership
BioAtla, Inc. Filed Acc 0001209191-21-067217
Chief Executive Officer sold 57,640 shares at an average $25.26 ($1,456,182)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SHORT JAY M PHD Chief Executive Officer | 2021-11-22 | Sale | −15,675 | $26.24 | $411,234 | 1,425,833 | D: show line 1 in the form |
| SHORT JAY M PHD Chief Executive Officer | 2021-11-23 | Sale | −15,861 | $24.29 | $385,184 | 1,409,972 | D: show line 2 in the form |
| SHORT JAY M PHD Chief Executive Officer | 2021-11-23 | Sale | −9,082 | $26.04 | $236,450 | 1,400,890 | D: show line 3 in the form |
| SHORT JAY M PHD Chief Executive Officer | 2021-11-24 | Sale | −6,311 | $24.05 | $151,798 | 1,394,579 | D: show line 4 in the form |
| SHORT JAY M PHD Chief Executive Officer | 2021-11-24 | Sale | −5,852 | $25.00 | $146,294 | 1,388,727 | D: show line 5 in the form |
| SHORT JAY M PHD Chief Executive Officer | 2021-11-24 | Sale | −4,859 | $25.77 | $125,221 | 1,383,868 | D: show line 6 in the form |
| Open-market sales · 57,640 sh · avg $25.26 · $1,456,182 | |||||||
Loading xslF345X03/doc4.xml…